lumark
i.d.b. radiopharmacy b.v. - lutetium (177lu) chloride - radionuclide imaging - therapeutic radiopharmaceuticals - lumark is a radiopharmaceutical precursor. it is not intended for direct use in patients. this medicinal must be used only for the radiolabelling of carrier molecules, which have been specifically developed and authorised for radiolabelling with this radionuclide.
hexin 4mg/5ml syrup
lumar pharmaceutical laboratory - bromhexine hydrochloride - syrup - 4mg/5ml
marluxyn 100mg/ 5ml syrup
lumar pharmaceutical laboratory - carbocisteine - syrup - 100mg/ 5ml
marluxyn 50mg/ ml syrup (oral drops)
lumar pharmaceutical laboratory - carbocisteine - syrup (oral drops) - 50mg/ ml
zinett 125mg/ 5ml suspension
lumar pharmaceutical laboratory - chloramphenicol (as palmitate) - suspension - 125mg/ 5ml
mervilar 4 mg tablet
lumar pharmaceutical laboratory - chlorphenamine maleate - tablet - 4 mg
trimoxavin 800mg/ 160mg tablet
lumar pharmaceutical laboratory - cotrimoxazole - tablet - 800mg/ 160mg
trimoxavin 200mg/ 40mg per 5ml suspension
lumar pharmaceutical laboratory - cotrimoxazole - suspension - 200mg/ 40mg per 5ml
trimoxavin 400mg/ 80mg capsule
lumar pharmaceutical laboratory - cotrimoxazole - capsule - 400mg/ 80mg
histazyn 12.5mg/ 5ml syrup
lumar pharmaceutical laboratory - diphenhydramine hydrochloride - syrup - 12.5mg/ 5ml